FABP4 and coronary artery disorder: While literature indicates that FABP4 levels increase in atherosclerotic diseases [19–24], a meta-analysis found that a 1-SD decrease in FABP4 among Type 1 diabetes mellitus patients increased the risk of CAD by 2.4-fold [25].